Jacqueline Shea
Patrimonio netto: 66 835 $ in data 31/10/2026
Patrimonio netto: 66 835 $ in data 31/10/2026
Jacqueline E.
Shea is President, Chief Executive Officer & Director at Inovio Pharmaceuticals, Inc. since 2022 and Trustee at Albert B. Sabin Vaccine Institute, Inc. since 2019.
Formerly, Dr. Shea was Chief Executive Officer at Aeras Global TB Vaccine Foundation from 2015 to 2018, Vice President-Europe Business Development at Emergent BioSolutions, Inc. from 2013 to 2014, and Vice President & General Manager at The Oxford-Emergent Tuberculosis Consortium Ltd. from 2008 to 2013.
Education includes undergraduate studies at the University of Bath and a doctorate from The National Institute For Medical Research.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 20/05/2026 | 111.021 ( 0,11% ) | 66 835 $ | 31/10/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| INOVIO PHARMACEUTICALS, INC. | Amministratore Delegato | 10/05/2022 |
Albert B. Sabin Vaccine Institute, Inc.
Albert B. Sabin Vaccine Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Creates solutions to health threats | Direttore/Membro del Consiglio | 13/08/2019 |
| Società | Posizione | Fine |
|---|---|---|
Aeras Global TB Vaccine Foundation
Aeras Global TB Vaccine Foundation Miscellaneous Commercial ServicesCommercial Services Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD. | Amministratore Delegato | 01/12/2018 |
| EMERGENT BIOSOLUTIONS INC. | Corporate Officer/Principal | 01/03/2014 |
The Oxford-Emergent Tuberculosis Consortium Ltd.
The Oxford-Emergent Tuberculosis Consortium Ltd. BiotechnologyHealth Technology Develops advanced vaccine for the prevention of tuberculosis | Corporate Officer/Principal | 01/01/2013 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 7 |
|---|---|
Aeras Global TB Vaccine Foundation
Aeras Global TB Vaccine Foundation Miscellaneous Commercial ServicesCommercial Services Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD. | Commercial Services |
Albert B. Sabin Vaccine Institute, Inc.
Albert B. Sabin Vaccine Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Creates solutions to health threats | Commercial Services |
University of Bath
University of Bath Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inovio Pharmaceuticals, Inc.
Inovio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops synthetic vaccines and immune therapies for cancers and infectious diseases | Health Technology |
Emergent BioSolutions, Inc.
Emergent BioSolutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
The National Institute For Medical Research
The National Institute For Medical Research Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Oxford-Emergent Tuberculosis Consortium Ltd.
The Oxford-Emergent Tuberculosis Consortium Ltd. BiotechnologyHealth Technology Develops advanced vaccine for the prevention of tuberculosis | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale